TY - JOUR
TI - Transient Tachypnea of the Newborn (TTN): A Role for Polymorphisms of Surfactant Protein B (SP-B) Encoding Gene? [Transiente Tachypnoe des Neugeborenen (TTN): Spielen Polymorphismen im Surfactant-Protein-B-Gen (SP-B) eine Rolle?]
AU - Tutdibi, E.
AU - Hospes, B.
AU - Landmann, E.
AU - Gortner, L.
AU - Satar, M.
AU - Yurdakök, M.
AU - Dellagrammaticas, H.
AU - Örs, R.
AU - Ilikkan, B.
AU - Ovali, F.
AU - Sarman, G.
AU - Kumral, A.
AU - Arslanoglu, S.
AU - Koc, H.
AU - Yildiran, A.
JO - Klinische Padiatrie
PY - 2003
VL - 215
TODO - 5
SP - 248-251
PB - 
SN - null
TODO - 10.1055/s-2003-42670
TODO - surfactant protein B, article;  birth weight;  breathing rate;  controlled study;  gene mutation;  genetic polymorphism;  genetic variability;  genomics;  heterozygosity;  human;  hypothesis;  intron;  major clinical study;  newborn;  oxygen saturation;  polymerase chain reaction;  protein function;  respiratory tract disease;  restriction fragment length polymorphism;  sequence analysis;  tachypnea;  thorax radiography;  transient tachypnea of the newborn, Age Factors;  Birth Weight;  Cesarean Section;  Female;  Gestational Age;  Heterozygote;  Humans;  Infant, Newborn;  Introns;  Male;  Mutation;  Polymerase Chain Reaction;  Polymorphism, Genetic;  Pulmonary Surfactant-Associated Protein B;  Respiration Disorders;  Respiratory Distress Syndrome, Newborn;  Risk Factors;  Sex Factors;  Time Factors;  Variation (Genetics)
TODO - Background: Transient tachypnea of the newborn (TTN) is usually a benign self-limiting respiratory disorder in the immediate neonatal period. The lipophilic surfactant-associated protein B (SP-B) was demonstrated to be the most relevant structural component of the surfactant system for immediate postnatal pulmonary adaptation. We hypothesized genetic variations of surfactant protein B (heterozygous 121 ins 2 mutation er intron 4 polymorphisms) to be related to TTN. Patients and Method: We screened genomic DNA of 83 healthy term neonates (gestational age: 39 (37-41) completed weeks [median and range]; birth weight: 3325 ± 541 grams [mean ± SD]) and 75 infants presenting with TTN (gestational age: 38 (37-41) completed wecks [median and range]; birth weight: 3091 ± 435 grams [mean ± SD]) by means of PCR-amplification, fragment length and sequence analysis. TTN was diagnosed an the basis of the clinical signs with respiratory rate > 60 breaths/minute, fraction of inspired oxygen > 0.21, and characteristic radiographic findings within less than 24 hours after birth. Newborns with any infection, pulmonary or cardiac congenital malformations, postnatal asphyxia and infants born to diabetic mothers were excluded. Results: In TTN-group the frequency of male infants (68.4% versus 44.6%, p < 0.05) and caeserian section were significantly higher (68.4% versus 30.1%, p < 0.05). We did not find any statistical difference in frequency of intron 4 variations between controls and TTN-group (8.4% versus 10.7%). None of the infants were heterozygous for the 121ins2 SP-B mutation. Conclusions: WC conclude polymorphisms of intron 4 and heterozygous 121 ins 2 mutation not to associated with TTN.
ER -